Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018
Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018
Fri, October 12, 2018
Thu, October 11, 2018
Wed, October 10, 2018
Tue, October 9, 2018

Madhu Kumar Upgraded (ABUS) to Strong Buy and Decreased Target to $9 on, Oct 16th, 2018


//stocks-investing.news-articles.net/content/201 .. -and-decreased-target-to-9-on-oct-16th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Madhu Kumar of B. Riley Securities, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Strong Buy and Decreased Target from $12 to $9 on, Oct 16th, 2018.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Driscoll of "Wedbush" Upgraded from Sell to Hold and Held Target at $5 on, Monday, October 15th, 2018

Publication Contributing Sources